Case number 1:25-cv-00753
Bayer Pharma AG et al v. Alembic Pharmaceuticals Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Oct 20, 2025 | 20 | SO ORDERED Granting (D.I. 19 in 25-cv-753-RGA; D.I. 376 in 21-md-3017-RGA-LDH) STIPULATION and Order for Extension of Time to respond to the Complaint thirty (30) days from the expiration of the stay pending appeal in related actions. Signed by Judge Richard G. Andrews on 10/20/2025. Associated Cases: 1:21-md-03017-RGA-LDH, 1:25-cv-00753-RGA(nms) (Entered: 10/20/2025) (2) |
| Oct 17, 2025 | 19 | STIPULATION and Order for Extension of Time to Respond to Complaint thirty (30) days from the expiration of the stay pending appeal in related actions - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Gaza, Anne) Modified on 10/17/2025 (nms). (Entered: 10/17/2025) (2) |
| Sep 30, 2025 | 18 | NOTICE of Appearance by Anne Shea Gaza on behalf of Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. (Gaza, Anne) (Entered: 09/30/2025) (3) |
| Sep 18, 2025 | 17 | STIPULATION and Order for Extension of Time to Respond to Complaint - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) Modified on 9/18/2025 (nms). (Entered: 09/18/2025) (2) |
| Sep 18, 2025 | N/A | SO ORDERED, re 17 STIPULATION and Order for Extension of Time to Respond to Complaint (*Reset Answer Deadlines: Alembic Global Holding SA answer due 10/20/2025; Alembic Pharmaceuticals Limited answer due 10/20/2025; Alembic Pharmaceuticals, Inc. answer due 10/20/2025). Signed by Judge Richard G. Andrews on 9/18/2025. (nms) (Entered: 09/18/2025) (0) |
| Sep 5, 2025 | 16 | STIPULATION and Order for Extension of Time to Respond to Complaint - filed by Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc.. (Wilson, Samantha) Modified on 9/5/2025 (nms). (Entered: 09/05/2025) (2) |
| Sep 5, 2025 | N/A | SO ORDERED, re 16 STIPULATION and Order for Extension of Time to Respond to Complaint (*Reset Answer Deadlines: Alembic Global Holding SA answer due 9/19/2025; Alembic Pharmaceuticals Limited answer due 9/19/2025; Alembic Pharmaceuticals, Inc. answer due 9/19/2025). Signed by Judge Richard G. Andrews on 9/5/2025. (nms) (Entered: 09/05/2025) (0) |
| Sep 3, 2025 | 13 | MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh - filed by Janssen Pharmaceuticals Inc., Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) (Entered: 09/03/2025) (11) |
| Sep 3, 2025 | 14 | Pro Hac Vice Fee - Credit Card Payment received for Stephanie P. Koh. ( re 13 MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh )( Payment of $ 50, receipt number ADEDC-4780513).(Fahnestock, Derek) (Entered: 09/03/2025) (0) |
| Sep 3, 2025 | N/A | SO ORDERED, re 13 MOTION for Pro Hac Vice Appearance of Attorney Stephanie P. Koh filed by Janssen Pharmaceuticals, Inc., Janssen Pharmaceuticals Inc.. Signed by Judge Richard G. Andrews on 9/3/2025. (aas) (Entered: 09/03/2025) (0) |
| Sep 3, 2025 | 15 | NOTICE requesting Clerk to remove Gwen Hochman Stewart as co-counsel. Reason for request: no longer associated with the case. (Fahnestock, Derek) (Entered: 09/03/2025) (9) |
| Jul 8, 2025 | 10 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.: For Alembic Pharmaceuticals Limited waiver sent on 7/7/2025, answer due 9/5/2025. (Fahnestock, Derek) (Entered: 07/08/2025) (1) |
| Jul 8, 2025 | 11 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.: For Alembic Pharmaceuticals, Inc. waiver sent on 7/7/2025, answer due 9/5/2025. (Fahnestock, Derek) (Entered: 07/08/2025) (1) |
| Jul 8, 2025 | 12 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.: For Alembic Global Holding SA waiver sent on 7/7/2025, answer due 9/5/2025. (Fahnestock, Derek) (Entered: 07/08/2025) (1) |
| Jun 25, 2025 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:25-cv-00753-UNA, 1:25-cv-00754-UNA (alb) (Entered: 06/25/2025) (0) |
| Jun 24, 2025 | N/A | CORRECTING ENTRY: The Complaint (D.I. 3 ) has been unsealed per the Order at D.I. 6 . (nms) (Entered: 06/24/2025) (0) |
| Jun 20, 2025 | 6 | ORAL ORDER: The motion to file the complaint under seal (D.I. 1 ) is denied. The description of the settlement is too general to think that public disclosure of the complaint or any part of it will work a serious harm to plaintiffs. Ordered by Judge Richard G. Andrews on 6/20/2025. (aas) Modified on 6/20/2025 (nms). (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | 9 | Summons Issued as to Alembic Global Holding SA on 6/20/2025; Alembic Pharmaceuticals Limited on 6/20/2025; Alembic Pharmaceuticals, Inc. on 6/20/2025. (Attachments: # 1 Summons Issued, # 2 Summons Issued)(mrr) (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | N/A | Remark: The MDL Panel has been notified of case 1:25-cv-00753-UNA which relates with 1:21-md-03017-RGA-LDH (mrr) (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | N/A | Remark: Exit electronic copies to Judge, RGA (mrr) (mrr) (Entered: 06/20/2025) (0) |
| Jun 20, 2025 | N/A | CORRECTING ENTRY: The docket text for D.I. 6 has been corrected to reflect the filing is an oral order. (nms) (Entered: 06/20/2025) (0) |
| Jun 18, 2025 | 1 | MOTION for Leave to File Complaint Under Seal - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (Attachments: # 1 Text of Proposed Order)(mrr) (Entered: 06/20/2025) (0) |
| Jun 18, 2025 | 2 | DECLARATION of David Schramm re 1 MOTION for Leave to File Complaint Under Seal by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/20/2025) (2) |
| Jun 18, 2025 | 3 | COMPLAINT with Jury Demand against Alembic Global Holding SA, Alembic Pharmaceuticals Limited, Alembic Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4714541) - filed by Bayer Pharma AG, Bayer AG, Janssen Pharmaceuticals, Inc.. (Attachments: # 1 Exhibits A-B, # 2 Civil Cover Sheet)(mrr) Modified on 6/24/2025 (nms). (Entered: 06/20/2025) (0) |
| Jun 18, 2025 | 4 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mrr) (Entered: 06/20/2025) (3) |
| Jun 18, 2025 | 5 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10, 828, 310 B2. (mrr) (Entered: 06/20/2025) (1) |
| Jun 18, 2025 | 7 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/20/2025) (1) |
| Jun 18, 2025 | 8 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc. (mrr) (Entered: 06/20/2025) (1) |
